| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |